Clinical depression historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(12 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Clinical depression}}
{{Clinical depression}}
{{CMG}}
{{CMG}}
==Overview==


==Historical Perspective==
==Historical Perspective==
[[Image:Vincent Willem van Gogh 002.jpg|thumb|200px|left|''On the Threshold of Eternity''. In 1890, [[Vincent van Gogh]] painted this picture seen by some as symbolizing the despair and hopelessness felt in depression. Van Gogh himself suffered from depression and committed[[suicide]] later that same year.]]


===Discovery===
The modern idea of depression appears similar to the much older concept of melancholia. The name ''[[melancholia]]'' derives from "black bile", one of the "[[four humours]]" postulated by [[Galen]].
The modern idea of depression appears similar to the much older concept of melancholia. The name ''[[melancholia]]'' derives from "black bile", one of the "[[four humours]]" postulated by [[Galen]].


Clinical depression was originally considered to be a [[chemical imbalance theory|chemical imbalance]] in transmitters in the brain, a theory based on observations made in the 1950s of the effects of [[reserpine]] and [[isoniazid]] in altering monoamine neurotransmitter levels and affecting depressive symptoms.<ref>{{cite journal | last = Schildkraut | first = J.J. |date=1965 | title =  The catecholamine hypothesis of affective disorders: a review of supporting evidence | journal = Am J Psychiatry | volume = 122 | issue = 5 | pages = 509-22}}</ref>  Since these suggestions, many other causes for clinical depression have been proposed.<ref name="chem">Castren, E. (2005). Is Mood Chemistry? Nat Rev Neurosci, : p6(3):241-6 PMID 15738959.</ref>
Clinical depression was originally considered to be a [[chemical imbalance theory|chemical imbalance]] in transmitters in the brain, a theory based on observations made in the 1950s of the effects of [[reserpine]] and [[isoniazid]] in altering monoamine neurotransmitter levels and affecting depressive symptoms. <ref>{{cite journal | last = Schildkraut | first = J.J. |date=1965 | title =  The catecholamine hypothesis of affective disorders: a review of supporting evidence | journal = Am J Psychiatry | volume = 122 | issue = 5 | pages = 509-22}}</ref>  Since these suggestions, many other causes for clinical depression have been proposed.<ref name="chem">Castren, E. (2005). Is Mood Chemistry? Nat Rev Neurosci, : p6(3):241-6 PMID 15738959.</ref>


Some medical professionals and anthropologists have formed several theories as to how depression may have evolutionary advantages, i.e., how it might have increased genetic fitness in ancestral populations.  For example, ''psychic pain'' may have evolved in an analogous way to [[pain|physical pain]] so that organisms avoid behaviour which hinders reproduction.  This insight may be helpful in counselling therapy.<ref>{{citation|title=Evolution, depression and counselling|journal=Counselling Psychology Quarterly|volume= Volume 18, Number 3|pages=215-222|date=September 2005|author=Tony J. Carey}}</ref><ref>{{citation|title=Is depression good for you?|url=http://news.bbc.co.uk/1/hi/magazine/7268496.stm|date=Thursday, 28 February 2008|author=Tom Geoghegan}}</ref> Proponents of the psychic pain theory tend to view clinical depression as a dysfunctional extreme of low mood or mild depression.
Some medical professionals and anthropologists have formed several theories as to how depression may have evolutionary advantages, i.e., how it might have increased genetic fitness in ancestral populations.  For example, psychic pain may have evolved in an analogous way to [[pain|physical pain]] so that organisms avoid behaviour that hinders reproduction.  This insight may be helpful in counseling therapy. <ref>{{citation|title=Evolution, depression and counselling|journal=Counselling Psychology Quarterly|volume= Volume 18, Number 3|pages=215-222|date=September 2005|author=Tony J. Carey}}</ref><ref>{{citation|title=Is depression good for you?|url=http://news.bbc.co.uk/1/hi/magazine/7268496.stm|date=Thursday, 28 February 2008|author=Tom Geoghegan}}</ref> Proponents of the psychic pain theory tend to view clinical depression as a dysfunctional extreme of low mood or mild depression.


==Archaic Methods of Treatment==
===Landmark events in development of strategies===
[[Insulin shock therapy]] is an old and largely abandoned treatment for severe depression, [[psychosis]], [[catatonia]], and other [[mental disorders]]. It consists of induction of [[hypoglycemia|hypoglycemic]] [[coma]] by [[intravenous infusion]] of [[insulin]]. 
*[[Insulin shock therapy]] is an old and largely abandoned treatment for severe depression, [[psychosis]], [[catatonia]], and other [[mental disorders]]. It consists of induction of [[hypoglycemia|hypoglycemic]] [[coma]] by [[intravenous infusion]] of [[insulin]].  
'''Atropinic shock therapy''', also known as [[atropine|atropinic]] coma therapy, is an old and rarely used method. It consists of induction of atropinic coma by rapid intravenous infusion of [[atropine]].


Atropinic shock treatment is considered safe, but it entails prolonged coma (between four and five hours), with careful monitoring and preparation, and it has many unpleasant side effects, such as blurred vision.
*Atropinic shock therapy, also known as [[atropine|atropinic]] coma therapy, is an old and rarely used method. It consists of induction of atropinic coma by rapid intravenous infusion of [[atropine]]. Atropinic shock treatment is considered safe, but it entails prolonged coma (between four and five hours), with careful monitoring and preparation, and it has many unpleasant side effects, such as blurred vision. <ref>{{cite journal |vauthors=Haenel T |title=[Historical notes on the therapy of depression] |language=German |journal=Schweiz Med Wochenschr |volume=116 |issue=47 |pages=1652–9 |date=November 1986 |pmid=3541174 |doi= |url=}}</ref>
 
*Treatment with psychotherapy including psychodynamic therapy and psychoanalysis was developed around the 19th century. <ref> {{cite journal |vauthors=Ebert A, Bär KJ |title=Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology |journal=Indian J Psychiatry |volume=52 |issue=2 |pages=191–2 |date=April 2010 |pmid=20838510 |pmc=2927892 |doi=10.4103/0019-5545.64591 |url=}}</ref>
* One of the first drugs used for the treatment of depression was imipramine. This was followed by other medications belonging to the class of tricyclic antidepressants (TCAs).
* Other antidepressants belonging to the class selective serotonin reuptake inhibitors (SSRIs) emerged
**Fluoxetine in 1987
** Sertraline in 1991
** Paroxetine in 1992
 
===Famous cases===
Numerous celebrities both dead and alive have been diagnosed with depression and spoken publicly about it. Some Hollywood celebrities include-
*Kristen Bell
*Jim Carrey
*Ellen Degeneres
*Cara Delevingne
*Johnny Depp
*Eminem
*Chris Evans
*Harrison Ford
*Joseph Gordon-Levitt
*Angelina Jolie
*Anne Hathaway
*Lady Gaga
*Hugh Laurie
*Dolly Parton


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Needs content]]
[[Category:Needs overview]]
[[Category:Disease]]
[[Category:Psychiatry]]

Latest revision as of 08:33, 16 February 2021

Clinical Depression Microchapters

Home

Patient Information

Major Depressive Disorder (Patient Information)

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Clinical Depression from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Substance/Medication-induced Depressive Disorder

Depressive Disorder due to a Medical Condition

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Psychotherapy

ECT

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-up

Follow-Up

Case Studies

Case #1

Clinical depression historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Clinical depression historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Clinical depression historical perspective

CDC on Clinical depression historical perspective

Clinical depression historical perspective in the news

Blogs on Clinical depression historical perspective

Directions to Hospitals Treating Clinical depression

Risk calculators and risk factors for Clinical depression historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Historical Perspective

On the Threshold of Eternity. In 1890, Vincent van Gogh painted this picture seen by some as symbolizing the despair and hopelessness felt in depression. Van Gogh himself suffered from depression and committedsuicide later that same year.

Discovery

The modern idea of depression appears similar to the much older concept of melancholia. The name melancholia derives from "black bile", one of the "four humours" postulated by Galen.

Clinical depression was originally considered to be a chemical imbalance in transmitters in the brain, a theory based on observations made in the 1950s of the effects of reserpine and isoniazid in altering monoamine neurotransmitter levels and affecting depressive symptoms. [1] Since these suggestions, many other causes for clinical depression have been proposed.[2]

Some medical professionals and anthropologists have formed several theories as to how depression may have evolutionary advantages, i.e., how it might have increased genetic fitness in ancestral populations. For example, psychic pain may have evolved in an analogous way to physical pain so that organisms avoid behaviour that hinders reproduction. This insight may be helpful in counseling therapy. [3][4] Proponents of the psychic pain theory tend to view clinical depression as a dysfunctional extreme of low mood or mild depression.

Landmark events in development of strategies

  • Atropinic shock therapy, also known as atropinic coma therapy, is an old and rarely used method. It consists of induction of atropinic coma by rapid intravenous infusion of atropine. Atropinic shock treatment is considered safe, but it entails prolonged coma (between four and five hours), with careful monitoring and preparation, and it has many unpleasant side effects, such as blurred vision. [5]
  • Treatment with psychotherapy including psychodynamic therapy and psychoanalysis was developed around the 19th century. [6]
  • One of the first drugs used for the treatment of depression was imipramine. This was followed by other medications belonging to the class of tricyclic antidepressants (TCAs).
  • Other antidepressants belonging to the class selective serotonin reuptake inhibitors (SSRIs) emerged
    • Fluoxetine in 1987
    • Sertraline in 1991
    • Paroxetine in 1992

Famous cases

Numerous celebrities both dead and alive have been diagnosed with depression and spoken publicly about it. Some Hollywood celebrities include-

  • Kristen Bell
  • Jim Carrey
  • Ellen Degeneres
  • Cara Delevingne
  • Johnny Depp
  • Eminem
  • Chris Evans
  • Harrison Ford
  • Joseph Gordon-Levitt
  • Angelina Jolie
  • Anne Hathaway
  • Lady Gaga
  • Hugh Laurie
  • Dolly Parton

References

  1. Schildkraut, J.J. (1965). "The catecholamine hypothesis of affective disorders: a review of supporting evidence". Am J Psychiatry. 122 (5): 509–22.
  2. Castren, E. (2005). Is Mood Chemistry? Nat Rev Neurosci, : p6(3):241-6 PMID 15738959.
  3. Tony J. Carey (September 2005), "Evolution, depression and counselling", Counselling Psychology Quarterly, Volume 18, Number 3: 215–222
  4. Tom Geoghegan (Thursday, 28 February 2008), Is depression good for you? Check date values in: |date= (help)
  5. Haenel T (November 1986). "[Historical notes on the therapy of depression]". Schweiz Med Wochenschr (in German). 116 (47): 1652–9. PMID 3541174.
  6. Ebert A, Bär KJ (April 2010). "Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology". Indian J Psychiatry. 52 (2): 191–2. doi:10.4103/0019-5545.64591. PMC 2927892. PMID 20838510.

Template:WikiDoc Sources